BYUNG SUK LIM: Open Payments
NPI 1093321663 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 78 payments from 19 companies in 2025. Trend: 2023 $665 · 2024 $1,438 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $322 |
| Lilly USA, LLC | 13 | $211 |
| Novo Nordisk Inc | 11 | $143 |
| Xeris Pharmaceuticals, Inc. | 6 | $103 |
| SANOFI-AVENTIS U.S. LLC | 5 | $82 |
| Mannkind Corporation | 5 | $74 |
| ABBVIE INC. | 4 | $70 |
| Corcept Therapeutics | 4 | $62 |
| Amgen Inc. | 3 | $52 |
| Tandem Diabetes Care, Inc. | 2 | $52 |
Products named: JARDIANCE, MOUNJARO, TZIELD, RECORLEV, AFREZZA, Rybelsus, Korlym, Wegovy.
Industry payments across NJ — which companies pay providers there.
